Hyundai Pharmaceutical Co., Ltd.
KRX:004310.KS
4,260 (KRW) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Hyundai Pharmaceutical Co., Ltd. |
Symbool | 004310.KS |
Munteenheid | KRW |
Prijs | 4,330 |
Beurswaarde | 120,567,862,760 |
Dividendpercentage | 0.93% |
52-weken bereik | 3,410 - 6,620 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Young-Hak Kim |
Website | https://www.hyundaipharm.co.kr |
An error occurred while fetching data.
Over Hyundai Pharmaceutical Co., Ltd.
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)